NASDAQ:CHFSCHF Solutions Stock Price, Forecast & News

$0.38

+0.00 (+0.80 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$0.38

Now: $0.38▼

$0.41

50-Day Range

$0.34

MA: $0.39▼

$0.46

52-Week Range

$0.30

Now: $0.38▼

$3.50

Volume4.08 million shs

Average Volume3.75 million shs

Market Capitalization$14.78 million

P/E RatioN/A

Dividend YieldN/A

Beta1.37

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CHF Solutions.

2.7 Community Rank

Outperform Votes
CHF Solutions has received 311 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CHF Solutions has received 272 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CHF Solutions has received 53.34% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote “Outperform” if you believe CHFS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CHF Solutions does not currently pay a dividend.
Dividend Growth
CHF Solutions does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CHF Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.40% of the stock of CHF Solutions is held by insiders.
Percentage Held by Institutions
Only 0.87% of the stock of CHF Solutions is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for CHF Solutions are expected to grow in the coming year, from ($0.65) to ($0.30) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CHF Solutions is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of CHF Solutions is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
CHF Solutions has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.67 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:CHFS

Previous SymbolNASDAQ:SSH

CUSIPN/A

CIK1506492

Webwww.chf-solutions.com

Phone952-345-4200

Debt

Debt-to-Equity Ratio0.03

Current Ratio4.10

Quick Ratio3.07

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$5.51 million

Price / Sales2.68

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.20 per share

Price / Book1.90

Profitability

EPS (Most Recent Fiscal Year)($9.30)

Net Income$-18,110,000.00

Net Margins-302.99%

Return on Equity-319.68%

Return on Assets-207.21%

Miscellaneous

Employees55

Outstanding Shares38,907,000

Market Cap$14.78 million

Next Earnings Date8/4/2020 (Estimated)

OptionableNot Optionable

Receive CHFS News and Ratings via Email

Sign-up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions

How has CHF Solutions' stock been impacted by COVID-19 (Coronavirus)?

CHF Solutions' stock was trading at $0.3125 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHFS shares have increased by 21.6% and is now trading at $0.38. View which stocks have been most impacted by Coronavirus.

When is CHF Solutions' next earnings date?

CHF Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for CHF Solutions.

How were CHF Solutions' earnings last quarter?

CHF Solutions Inc (NASDAQ:CHFS) announced its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.78) by $0.41. The business had revenue of $1.63 million for the quarter. CHF Solutions had a negative net margin of 302.99% and a negative return on equity of 319.68%. View CHF Solutions' earnings history.

When did CHF Solutions' stock split? How did CHF Solutions' stock split work?

CHF Solutions's stock reverse split on the morning of Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.

Has CHF Solutions been receiving favorable news coverage?

Press coverage about CHFS stock has been trending extremely negative on Friday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CHF Solutions earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutCHF Solutions.

Who are some of CHF Solutions' key competitors?

Some companies that are related to CHF Solutions include Fc Global Realty (FCRE), electroCore (ECOR), IRIDEX (IRIX), Reshape Lifesciences (RSLS), Helius Medical Technologies (HSDT), Precision Optics (PEYE), Second Sight Medical Products (EYES), ENDRA Life Sciences (NDRA), Viveve Medical (VIVE), Vaso (VASO), Digirad (DRAD), Non-Invasive Monitoring Systems (NIMU), ReShape Lifesciences (RSLSD), Trimedyne (TMED) and Nexeon Medsystems (NXNN). View all competitors.

What other stocks do shareholders of CHF Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CHF Solutions investors own include IMMUTEP LTD/S (IMMP), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), VBI Vaccines (VBIV), Melinta Therapeutics (MLNT), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Bausch Health Companies (BHC) and Ibio (IBIO).

Who are CHF Solutions' key executives?

CHF Solutions' management team includes the following people:

Mr. John L. Erb, Chairman, CEO & Pres (Age 70)
Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)
Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)
Mr. David Lerner, Sr. VP of Corp. Devel. & Technology
Mr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52)

What is CHF Solutions' stock symbol?

CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."

Who are CHF Solutions' major shareholders?

CHF Solutions' stock is owned by many different retail and institutional investors. Top institutional shareholders include Searle & CO. (0.31%), Advisor Group Holdings Inc. (0.18%) and UBS Group AG (0.19%). Company insiders that own CHF Solutions stock include Gregory D Waller and John L Erb. View institutional ownership trends for CHF Solutions.

Which institutional investors are buying CHF Solutions stock?

CHFS stock was bought by a variety of institutional investors in the last quarter, including Searle & CO., Advisor Group Holdings Inc., and UBS Group AG. View insider buying and selling activity for CHF Solutions.

How do I buy shares of CHF Solutions?

Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CHF Solutions' stock price today?

One share of CHFS stock can currently be purchased for approximately $0.38.

How big of a company is CHF Solutions?

CHF Solutions has a market capitalization of $14.78 million and generates $5.51 million in revenue each year. The company earns $-18,110,000.00 in net income (profit) each year or ($9.30) on an earnings per share basis. CHF Solutions employs 55 workers across the globe.

What is CHF Solutions' official website?

The official website for CHF Solutions is www.chf-solutions.com.

How can I contact CHF Solutions?

CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff